glp-1 ckd and the kidney: from physiology to pharmacology and outcomes in diabetes image3.png

The tabloid body narrative runs until the next piece of work drops

2013 paper (PMID: 23055539) has an Expression of Concern issued by the journal in 2021, and the Benoist et al

Semaglutide Options Semaglutide is the most widely prescribed GLP-1 receptor agonist for weight management

A supplement that mildly stimulates your L-cells to produce slightly more GLP-1 for slightly longer is not the same as a medication that floods your GLP-1 receptors with a synthetic agonist 24 hours a day for a week at a time

Estudios publicados en The New England Journal of Medicine han demostrado que molculas como la semaglutida y la tirzepatida pueden inducir prdidas de peso sostenidas de entre 15% y 22%, cifras que hasta hace pocos aos estaban reservadas casi exclusivamente para intervenciones quirrgicas como la ciruga baritrica